Product
FES
2 clinical trials
5 indications
Indication
Breast CancerIndication
Lobular Carcinoma of the BreastIndication
PET/MRIIndication
Axillary LymphadenopathyIndication
Luminal A Breast CancerClinical trial
Dynamic and Test-retest Whole Body [18F]FES PET Imaging in Patients With Metastatic ER+ Breast CancerStatus: Recruiting, Estimated PCD: 2025-04-01
Clinical trial
18F-FES PET/MRI for Tailoring Treatment of Luminal A and Lobular Breast Cancer: a Phase II Prospective Cohort Study Evaluating the Performance of FES PET/MRI in Axillary Staging Compared With Axillary SurgeryStatus: Not yet recruiting, Estimated PCD: 2027-05-15